Methylprednisolone Acetate Injection Suspension
- Packing: 1 Ml, 2 Ml Vial
- Available Strength : 40 Mg/Ml
Description
Product Description: Methylprednisolone Acetate Injection Suspension is a sterile suspension containing methylprednisolone acetate, a synthetic glucocorticoid. It is formulated for intramuscular administration and is commonly used for its anti-inflammatory and immunosuppressive properties.
Indications and Usage: Methylprednisolone Acetate Injection Suspension is indicated for the treatment of various conditions requiring corticosteroid therapy, including allergic reactions, arthritis, dermatologic disorders, and certain hematologic disorders.
Dosage and Administration: The dosage of Methylprednisolone Acetate Injection Suspension depends on the specific condition being treated, its severity, and the patient's response to therapy. It is typically administered by deep intramuscular injection into the gluteal muscle or deltoid muscle. Dosages may vary but commonly range from 10 mg to 80 mg per day.
Dosage Forms and Strengths: Methylprednisolone Acetate Injection Suspension is available as a sterile suspension in vials. The suspension is typically supplied in concentrations of 40 mg/mL or 80 mg/mL.
Contraindications: Methylprednisolone Acetate Injection Suspension is contraindicated in patients with systemic fungal infections, known hypersensitivity to corticosteroids or any component of the formulation, and in patients with idiopathic thrombocytopenic purpura.
Warnings and Precautions: Before initiating treatment with Methylprednisolone Acetate Injection Suspension, healthcare providers should assess patients for contraindications, including systemic infections, gastrointestinal disorders, and diabetes mellitus. Prolonged use may increase the risk of adrenal suppression, osteoporosis, and opportunistic infections.
Adverse Reactions/Side Effects: Common adverse reactions associated with Methylprednisolone Acetate Injection Suspension include injection site reactions, fluid retention, hypertension, hyperglycemia, and gastrointestinal disturbances. Other potential side effects may include immunosuppression, psychiatric reactions, and dermatologic reactions.
Drug Interactions: Methylprednisolone Acetate Injection Suspension may interact with certain medications, including anticoagulants, antidiabetic agents, and immunosuppressants. Concomitant use with other corticosteroids may increase the risk of adrenal suppression.
Use In Specific Populations Description: Methylprednisolone Acetate Injection Suspension is generally considered safe for use in pregnant and lactating women when the potential benefits outweigh the risks. Caution should be exercised in pediatric patients, as corticosteroid therapy may affect growth and development.
How Supplied/Storage and Handling: Methylprednisolone Acetate Injection Suspension is supplied as a sterile suspension in vials. It should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), protected from light and moisture. Unused portions should be discarded according to local regulations for biohazardous waste disposal.
